DOI: 10.22270/jmpas.V10I1.980

VOLUME - 10 ISSUE - 1 JANUARY-FEBRUARY 2021

BULLOUS ERUPTIONS IN A PATIENT OF SYSTEMIC LUPUS ERYTHEMATOSUS

Das Somnath*, Chatterjee Gobinda, Nayak Parthasarathi, Prakash Aishwarya, Rudra Olympia,
Mandal Aniruddha

Institute of Post Graduate Medical Education and Research (IGPMER), Kolkata, West Bengal, India

ABSTRACT

Fixed drug eruption (FDE) is a cutaneous adverse drug reaction characterized by recurrent well‐defined lesions occurring in the same sites each time the offending drug is taken. FDEs account for 4–39% of all drug eruptions. Commonly affected sites include the lips, genitals, palms, and soles. Typically, FDE presents as a sharply‐defined, round or oval erythematous and oedematous plaque which evolves to become dusky, violaceous, and occasionally vesicular or bullous. Giant bullous variant is an uncommon manifestation of FDE

Keywords:

Fixed drug eruption, Giant bullous FDE, Systemic lupus erythematous, Mefenamic acid, Bullous eruption


Full Text Article